0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query hjresearch global pulmonary arterial hypertension pah medicine industry market research 2018.Your search for "" gave back 1533063 results.
Tracleer (bosentan) is a prescription medicine indicated for patients with certain types of pulmonary arterial hypertension (PAH, WHO Group 1), which...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Vivus, Inc. - Strategy, SWOT and Corporate Finance Report Summary Vivus, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
January 2021
Price: USD 175.00
The global Tracleer (bosentan) market size was valued at US$ million in 2023. With growing demand in downstream market, the Tracleer (bosentan) is...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The triad of congenital systemic-to-pulmonary communication, cyanosis, and pulmonary arterial disease is called Eisenmenger syndrome. Eisenmenger...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) – Pipeline Review, H1 2018 Summary Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) pipeline Target...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
Tracleer (bosentan) is a prescription medicine indicated for patients with certain types of pulmonary arterial hypertension (PAH, WHO Group 1), which...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...
Catalog:
Global Markets Direct
April 2022
Price: USD 3,500.00
Arterial Thrombosis (Cardiovascular) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
July 2021
Price: USD 2,000.00
Arterial Thrombosis - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
September 2020
Price: USD 2,000.00
The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The triad of congenital systemic-to-pulmonary communication, cyanosis, and pulmonary arterial disease is called Eisenmenger syndrome. Eisenmenger...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Epoprostenol sodium directly simulates prostaglandin receptors in arterial vascular smooth muscle, thereby causing vasodilatation. The global...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Epoprostenol sodium directly simulates prostaglandin receptors in arterial vascular smooth muscle, thereby causing vasodilatation. The global...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The triad of congenital systemic-to-pulmonary communication, cyanosis, and pulmonary arterial disease is called Eisenmenger syndrome. Eisenmenger...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Arterial Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,000.00
